Costs associated with Alzheimer's disease in Italy: baseline results from the GERAS II observational study

被引：0
|
作者：
Bruti, G. [1 ]
Bruno, G. [2 ]
Mancini, M. [1 ]
Reed, C. [3 ]
机构：
[1] Eli Lilly Italy, Global Patient Safety Neurosci, Florence, Italy
[2] Univ Rome, Dept Neurol & Psychiat, Rome, Italy
[3] Eli Lilly & Co Ltd, Global Patient Outcomes & Real World Evidence, Windlesham, Surrey, England
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2016年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S61 / S62
页数：2
相关论文
共 50 条
  • [1] Determinants of societal costs in Alzheimer's disease: GERAS study baseline results
    Dodel, Richard
    Belger, Mark
    Reed, Catherine
    Wimo, Anders
    Jones, Roy W.
    Happich, Michael
    Argimon, Josep M.
    Bruno, Giuseppe
    Vellas, Bruno
    Maria Haro, Josep
    ALZHEIMERS & DEMENTIA, 2015, 11 (08) : 933 - 945
  • [2] Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study
    Bruno, G.
    Mancini, M.
    Bruti, G.
    Dell'Agnello, G.
    Reed, C.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2018, 5 (01): : 55 - 64
  • [3] Costs and Resource Use Associated with Alzheimer’s Disease in Italy: Results from an Observational Study
    G. Bruno
    Michele Mancini
    G. Bruti
    G. Dell’Agnello
    C. Reed
    The Journal of Prevention of Alzheimer's Disease, 2018, 5 : 55 - 64
  • [4] Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study
    Olazaran, Javier
    Aguera-Ortiz, Luis
    Maria Argimon, Josep
    Reed, Catherine
    Ciudad, Antonio
    Andrade, Paula
    Dilla, Tatiana
    INTERNATIONAL PSYCHOGERIATRICS, 2017, 29 (12) : 2081 - 2093
  • [5] Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
    Nakanishi, Miharu
    Igarashi, Ataru
    Ueda, Kaname
    Brnabic, Alan J. M.
    Treuer, Tamas
    Sato, Masayo
    Kahle-Wrobleski, Kristin
    Meguro, Kenichi
    Yamada, Masahito
    Mimura, Masaru
    Arai, Heii
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 127 - 138
  • [6] HEALTH STATE VALUES IN ALZHEIMER'S DISEASE - BASELINE RESULTS FROM A LARGE PROSPECTIVE OBSERVATIONAL STUDY IN THREE EUROPEAN COUNTRIES (GERAS)
    Reed, C.
    Argimon, J.
    Belger, M. A.
    Bruno, G.
    Dodel, R.
    Happich, M.
    Haro, J. M.
    Jones, R. W.
    Vellas, B.
    Wimo, A.
    VALUE IN HEALTH, 2012, 15 (07) : A554 - A554
  • [7] The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries - Study Design and Baseline Findings
    Wimo, Anders
    Reed, Catherine C.
    Dodel, Richard
    Belger, Mark
    Jones, Roy W.
    Happich, Michael
    Argimon, Josep M.
    Bruno, Giuseppe
    Novick, Diego
    Vellas, Bruno
    Maria Haro, Josep
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 36 (02) : 385 - 399
  • [8] Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study
    Rapp, Thomas
    Andrieu, Sandrine
    Chartier, Florence
    Deberdt, Walter
    Reed, Catherine
    Belger, Mark
    Vellas, Bruno
    VALUE IN HEALTH, 2018, 21 (03) : 295 - 303
  • [9] Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study
    Lenox-Smith, Alan
    Reed, Catherine
    Lebrec, Jeremie
    Belger, Mark
    Jones, Roy W.
    BMC GERIATRICS, 2016, 16 : 1 - 10
  • [10] Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
    Alan Lenox-Smith
    Catherine Reed
    Jeremie Lebrec
    Mark Belger
    Roy W. Jones
    BMC Geriatrics, 16
12345